Cargando…
Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists
Non-adrenergic prostate smooth muscle contractions may account for the limited effectiveness of α(1)-adrenoceptor antagonists, which are the first-line option for medical treatment of voiding symptoms suggestive of benign prostatic hyperplasia. In non-human prostates, purinergic agonists induce cont...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208936/ https://www.ncbi.nlm.nih.gov/pubmed/33427927 http://dx.doi.org/10.1007/s00210-020-02044-4 |
_version_ | 1783709023977078784 |
---|---|
author | Spek, Annabel Li, Bingsheng Rutz, Beata Ciotkowska, Anna Huang, Ru Liu, Yuhan Wang, Ruixiao Strittmatter, Frank Waidelich, Raphaela Stief, Christian G. Hennenberg, Martin |
author_facet | Spek, Annabel Li, Bingsheng Rutz, Beata Ciotkowska, Anna Huang, Ru Liu, Yuhan Wang, Ruixiao Strittmatter, Frank Waidelich, Raphaela Stief, Christian G. Hennenberg, Martin |
author_sort | Spek, Annabel |
collection | PubMed |
description | Non-adrenergic prostate smooth muscle contractions may account for the limited effectiveness of α(1)-adrenoceptor antagonists, which are the first-line option for medical treatment of voiding symptoms suggestive of benign prostatic hyperplasia. In non-human prostates, purinergic agonists induce contractions reaching similar magnitudes as α(1)-adrenergic contractions. However, evidence for the human prostate is highly limited, and pointed to much weaker purinergic contractions. Here, we examined contractions of different purinergic agonists in human prostate tissues. Tissues were obtained from radical prostatectomy. Contractions were studied in an organ bath, and expression of purinergic receptors was studied by RT-PCR. Electric field stimulation (EFS)–induced contractions amounted to 104% of KCl-induced contractions (95% CI: 84–124%). From all tested agonists, only ATP induced concentration-dependent contractions, reaching an average maximum of 18% (12–24%) of KCl. Maximum tensions following application of other agonists averaged to 7.1% of KCl for α,β-methylene-ATP (1.8–12.4%), 3.9% for β,γ-methylene-ATP (2.0–5.4%), 3.1% for 2-methylthio-ATP (− 0.1–6.3%), and 5.1% for ATPγS (1.0–9.2%). Responses were not affected by the P2X antagonist NF023 or the P2Y antagonist PPADS. mRNA expression of P2X1-4 correlated with expression of a marker for catecholaminergic nerves, although neither ATP, NF023, nor PPADS changed EFS-induced contractions. Correlation between expression of receptors and the smooth muscle marker calponin was not observed. Our findings point to a low relevance of purinergic contractions in the human prostate, compared to other contractile stimuli in the human prostate and compared to purinergic contractions in non-human prostates. Purinergic contractions in the human prostate are not sensitive to NF023 or PPADS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00210-020-02044-4. |
format | Online Article Text |
id | pubmed-8208936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-82089362021-07-01 Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists Spek, Annabel Li, Bingsheng Rutz, Beata Ciotkowska, Anna Huang, Ru Liu, Yuhan Wang, Ruixiao Strittmatter, Frank Waidelich, Raphaela Stief, Christian G. Hennenberg, Martin Naunyn Schmiedebergs Arch Pharmacol Original Article Non-adrenergic prostate smooth muscle contractions may account for the limited effectiveness of α(1)-adrenoceptor antagonists, which are the first-line option for medical treatment of voiding symptoms suggestive of benign prostatic hyperplasia. In non-human prostates, purinergic agonists induce contractions reaching similar magnitudes as α(1)-adrenergic contractions. However, evidence for the human prostate is highly limited, and pointed to much weaker purinergic contractions. Here, we examined contractions of different purinergic agonists in human prostate tissues. Tissues were obtained from radical prostatectomy. Contractions were studied in an organ bath, and expression of purinergic receptors was studied by RT-PCR. Electric field stimulation (EFS)–induced contractions amounted to 104% of KCl-induced contractions (95% CI: 84–124%). From all tested agonists, only ATP induced concentration-dependent contractions, reaching an average maximum of 18% (12–24%) of KCl. Maximum tensions following application of other agonists averaged to 7.1% of KCl for α,β-methylene-ATP (1.8–12.4%), 3.9% for β,γ-methylene-ATP (2.0–5.4%), 3.1% for 2-methylthio-ATP (− 0.1–6.3%), and 5.1% for ATPγS (1.0–9.2%). Responses were not affected by the P2X antagonist NF023 or the P2Y antagonist PPADS. mRNA expression of P2X1-4 correlated with expression of a marker for catecholaminergic nerves, although neither ATP, NF023, nor PPADS changed EFS-induced contractions. Correlation between expression of receptors and the smooth muscle marker calponin was not observed. Our findings point to a low relevance of purinergic contractions in the human prostate, compared to other contractile stimuli in the human prostate and compared to purinergic contractions in non-human prostates. Purinergic contractions in the human prostate are not sensitive to NF023 or PPADS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00210-020-02044-4. Springer Berlin Heidelberg 2021-01-11 2021 /pmc/articles/PMC8208936/ /pubmed/33427927 http://dx.doi.org/10.1007/s00210-020-02044-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Spek, Annabel Li, Bingsheng Rutz, Beata Ciotkowska, Anna Huang, Ru Liu, Yuhan Wang, Ruixiao Strittmatter, Frank Waidelich, Raphaela Stief, Christian G. Hennenberg, Martin Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists |
title | Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists |
title_full | Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists |
title_fullStr | Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists |
title_full_unstemmed | Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists |
title_short | Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists |
title_sort | purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208936/ https://www.ncbi.nlm.nih.gov/pubmed/33427927 http://dx.doi.org/10.1007/s00210-020-02044-4 |
work_keys_str_mv | AT spekannabel purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT libingsheng purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT rutzbeata purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT ciotkowskaanna purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT huangru purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT liuyuhan purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT wangruixiao purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT strittmatterfrank purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT waidelichraphaela purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT stiefchristiang purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists AT hennenbergmartin purinergicsmoothmusclecontractionsinthehumanprostateestimationofrelevanceandcharacterizationofdifferentagonists |